Subscribe to our Newsletter so you won't miss out on any essential information.
7 steps for pharma to protect a New Product Introduction from failure
A New Product Introduction, NPI, is a complex and risky process. Even though approval dates are often not known in advance, transport must take place immediately after approval and must follow the specific requirements of the pharmaceutical. Damaged batches or delays could put the whole product launch at risk and could even have devastating consequences for the company and ultimately the patients. Here are seven steps that quality managers could use as a guide to protect the NPI process and to build operational excellence.